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Abstract
Background: Anal HPV infection, which contributes to the development of anal warts and anal cancer, is well known to be
common among men who have sex with men (MSM), especially among those HIV positives. However, HIV and anal HPV co-
infection among MSM has not been addressed in China.
Methods: A cross-sectional study was conducted in Beijing and Tianjin, China. Study participants were recruited using
multiple methods with the collaboration of local volunteer organizations. Blood and anal swabs were collected for HIV-1
serological test and HPV genotyping.
Results: A total of 602 MSM were recruited and laboratory data were available for 578 of them (96.0%). HIV and anal HPV
prevalence were 8.5% and 62.1%, respectively. And 48 MSM (8.3%) were found to be co-infected. The HPV genotypes
identified most frequently were HPV06 (19.6%), HPV16 (13.0%), HPV52 (8.5%) and HPV11 (7.6%). Different modes of HPV
genotypes distribution were observed with respect to HIV status. A strong dose-response relationship was found between
HIV seropositivity and multiplicity of HPV genotypes (p,0.001), which is consistent with the observation that anal HPV
infection was an independent predictor for HIV infection.
Conclusions: A high prevalence of HIV and anal HPV co-infection was observed in the MSM community in Beijing and
Tianjin, China. Anal HPV infection was found to be independently associated with increased HIV seropositivity, which
suggests the application of HPV vaccine might be a potential strategy to reduce the acquisition of HIV infection though
controlling the prevalence of HPV.
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Introduction
Genital Human papillomaviruse (HPV) infections are very
common and are sexually transmitted [1]. The outcome of HPV
infectiondependsonitsoncogenictype(low-riskorhigh-risk).Genital
warts are most commonly associated with two low-risk types, HPV6
and HPV11 [2]. It has been well established that high-risk types, such
as HPV16 and HPV18, are the primary cause of cervical cancer [3].
High-risk HPV is also suggested to play a key role for the
development of anal cancer and precancerous lesions [4,5].
In the general population, anal cancer is a rare disease. Each
year it is diagnosed in about two people out of every 100,000
people [6]. However, among men who have sex with men (MSM),
and especially those HIV positives, the incidence of anal cancer is
significantly more prevalent and increasing annually [7]. Studies
from Western countries suggested that anal HPV is present in
approximately 65% of HIV negative MSM and 95% of MSM
who are HIV positive [8–10]. The high prevalence of HPV
infection is regarded to contribute to the higher risk of genital
warts and anal cancer. Moreover, anal HPV infection, especially
high-risk types, was suggested to be independently associated with
HIV acquisition [11–13]. In recent years, HPV vaccines have
been introduced in many countries with success to achieve
significant reduction in persistent HPV infection and its related
outcomes in both women and men [14]. If the causal link between
HPV infection and HIV acquisition was well established,
application of HPV vaccine could be a potential strategy for
HIV prevention in the high-risk population.
In China, the prevalence of HIV/AIDS and other sexually
transmitted diseases (STDs) is rapidly rising among MSM in the
past decade, which draws great concern of the public health fields
[15]. However, to our knowledge, prevalence of anal HPV
infection and its association with HIV among this high-risk
population has not been addressed in China. The aim of this pilot
cross-sectional study was to investigate the status of HIV and anal
HPV infection among MSM in Beijing and Tianjin, China.
Results
Subject recruitment and characteristics
In total, 607 eligible participations were interviewed and signed
the informed consent, 5 of them were excluded (3 did not
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leading to a final study population of 602 (302 from Beijing and
300 from Tianjin). As shown in Table 1, major characteristics of
the study population were evaluated by site, No significant
difference was found for any character (p.0.05). Therefore,
subjects from the two sites were pooled together for further
association analyses. The majority of participants were younger
than 30 years (69.7%), Han nationality (95.0%), self-reported
homosexual tendency (72.6%), and had the first homosexual act
at 18 years old or later (88%). Minority nationalities were
distributed in the study participants as: Hui (1.5%), Manchu
(1.5%), MongoljEn (0.5%), Miao (0.3%), Uyghur (0.3%), Korean
(0.3%), Chuang (0.2%), Tujia (0.2%) and Sui (0.2%). There were
23.3% participants reported a history of STDs other than HIV.
Laboratory data suggested a prevalence of 8.5% of HIV
seropositivity among the study population.
Anal HPV type distribution
As shown in Table 2, the genotyping results of HPV were
available for 578 participants (96%), 62.1% of them were positive
for at least one of targeted 26 HPV types. Among HPV positives,
47.1% (169/359) of them were multiple types infected. HIV
positives were almost always infected with HPV (96.0%), and
much lower prevalence was observed among HIV negatives
(58.9%). HPV06 (19.6%), HPV16 (13.0%), HPV52 (8.5%) and
HPV11 (7.6%) were found to be the most frequently identified
types. Higher prevalence was observed for most tested types
among HIV positives as compared to HIV negatives, and the
difference was statistically significant for several HPV types.
Risk factors for anal HPV infection
The association between potential risk factors and anal HPV
infection was assessed by logistic regression analysis as shown in
Table 1. Characteristics of the study population by study site.
Total (N=602)
n* (%) By site
Beijing (N=302)
n
* (%)
Tianjin (N=300)
n
* (%) p for difference
Age
#19 years 37 (6.1) 18 (6.0) 19 (6.3) 0.195
20–29 years 383 (63.6) 184 (60.9) 199 (66.3)
30–39 years 111 (18.4) 66 (21.9) 45 (15.0)
$40 years 71 (11.8) 34 (11.3) 37 (12.3)
Ethnicity
Han 570 (95.0) 285 (94.7) 285 (95.3) 0.729
Others 30 (5.0) 16 (5.3) 14 (4.7)
Education
#9 years 108 (18.0) 64 (21.3) 44 (14.7) 0.065
10–12 years 183 (30.5) 93 (31.0) 90 (30.0)
.12 years 309 (51.5) 143 (47.7) 166 (55.3)
Marriage status
Unmarried 467 (77.7) 232 (77.1) 235 (78.3) 0.711
Married 134 (22.3) 69 (22.9) 65 (21.7)
Self-reported sexual orientation
Homosexual 426 (72.6) 204 (69.2) 222 (76.0) 0.062
Bisexual/heterosexual 161 (27.4) 91 (30.9) 70 (24.0)
Ever had sex with women
Yes 223 (37.1) 117 (38.9) 106 (35.3) 0.370
No 378 (62.9) 184 (61.1) 194 (64.1)
Age at the first homosexual act
,18 years 72 (12.0) 41 (13.6) 31 (10.4) 0.220
$18 years 528 (88.0) 260 (86.4) 268 (89.6)
Ever had STDs other than HIV-1
No 454 (76.7) 217 (73.6) 237 (79.8) 0.073
Yes 138 (23.3) 78 (26.4) 60 (20.2)
HIV-1 serostatus
Negative 551 (91.5) 272 (90.1) 279 (93.0) 0.196
Positive 51 (8.5) 30 (9.9) 21 (7.0)
Abbreviation: STD, sexual transmitted disease.
*Sum may not always add up to total because of missing data.
doi:10.1371/journal.pone.0015256.t001
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nationality, taking oral sex and anilinction as regular sexual
behaviors, and ever found sexual partner in gay venues (e.g., MSM
clubs, bars, parks and bathhouses) were associated with increased
risk of anal HPV infection. Lower prevalence was observed for
those with higher education level (.12 years). Then, such
identified significant predictors, together with age, were included
in a multiple logistic regression analysis. The associations of
education and oral sex were not significant anymore. Stepwise
backward selection identified minority nationality, oral sex, and
ever found sexual partner in gay venues were independent
predictors with adjusted OR of 3.28 (1.21–8.89), 1.76 (1.22–
2.55), and 1.86 (1.25–2.76) respectively.
Risk factors for HIV infection
As shown in Table S3 and Table S4, ethnicity, education, age at
the first homosexual act, frequency of homosexual behaviors in the
past 6 months, ever found sexual partners in gay venues and anal
HPV status were significantly associated with HIV seropositivity in
univariate analyses.Onlytheassociationsforthelattertwo predictors
were still significant in the multiple logistic regression analysis.
Stepwise backward selection also identified these two predictors, ever
found sexual partners in gay venues and anal HPV status, were
independent risk factors for HIV seropositivity with adjusted OR of
3.76 (1.90–7.43) and 15.16 (3.62–63.60), respectively.
The association between HIV seropositivity and anal HPV
infection
The association between HIV seropositivity and anal HPV
infection was further analyzed according to HPV oncogenic type
and the number of co-infected HPV types as shown in Table 3.
Both low-risk and high-risk type were found to be significantly
related to HIV seropositivity. There was a significant association
between HPV multiplicity and the prevalence of HIV.
Discussion
This pilot study, for the first time, investigated molecular
epidemiological characteristics of anal HPV infection among
MSM in China. In addition, association between HIV seropos-
itivity and anal HPV infection was also addressed. In a total of 602
study subjects, HIV and anal HPV prevalence were 8.5% and
62.1%, respectively. And 96.0% HIV positives were anal HPV co-
infected. HPV infection was identified as an independent predictor
Table 2. Anal HPV type distribution according to HIV-1 serostatus.
HPV type*
Total (N=578)
n (%) HIV-1 serostatus
Negatives (N=528)
n( % )
Positives (N=50)
n (%) p for difference
Total
Any type 359 (62.1) 311 (58.9) 48 (96.0) ,0.001
Single type 190 (32.9) 169 (32.0) 21 (42.0) 0.151
Multiple types 169 (29.2) 142 (26.9) 27 (54.0) 0.002
High-risk
16 75 (13.0) 58 (11.0) 17 (34.0) ,0.001
18 34 (5.9) 27 (5.1) 7 (14.0) 0.011
31 0 0 0
33 20 (3.5) 15 (2.8) 5 (10.0) 0.008
35 2 (0.4) 2 (0.4) 0 0.663
39 36 (6.2) 34 (6.4) 2 (4.0) 0.495
45 31 (5.4) 24 (4.6) 7 (14.0) 0.005
51 21 (3.6) 15 (2.8) 6 (12) ,0.001
52 49 (8.5) 40 (7.6) 9 (18.0) 0.011
26/55 16 (2.8) 14 (2.7) 2 (4.0) 0.579
56 6 (1.0) 4 (0.8) 2 (4.0) 0.031
58 38 (6.6) 32 (6.1) 6 (12.0) 0.105
59 22 (3.8) 22 (4.2) 0 0.141
66 2 (0.4) 0 2 (4.0) ,0.001
68 24 (4.2) 24 (4.5) 0 0.124
83 12 (2.1) 11 (2.1) 1 (2.0) 0.969
Low-risk
6 113 (19.6) 98 (18.6) 15 (30.0) 0.051
11 44 (7.6) 39 (7.4) 5 (10.0) 0.503
40/42/44 10 (1.7) 8 (1.5) 2 (4.0) 0.197
61/73 45 (7.8) 39 (7.4) 6 (12.0) 0.243
*Classification of HPV types, according to carcinogenicity, is recommended by Tellgenplex
TM HPV DNA Test.
doi:10.1371/journal.pone.0015256.t002
HIV and Anal HPV Infection Among MSM
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15256for HIV seropositivity, and a significant relationship was found
between HIV seropositivity and multiplicity of HPV types.
In the past decades, several studies have shown that anal HPV
infection is common among MSM and is almost always present in
HIV positive MSM. In 1998, a study from the United States
reported 93% of 346 HIV positive and 61% of 262 HIV negative
MSM had anal HPV infection [8]. In recent years, several studies
from different MSM populations consistently reported such a
universal prevalence of anal HPV infection and multiple HPV type
infection was found to be common [16–19]. Moreover, anal HPV
infection, especially high-risk type, was suggested to be indepen-
dently associated with HIV acquisition [11–13]. The mechanisms
are not clear yet, but there is a biology plausibility that HPV
infectionrelatedlesionsmayleadtoanactivecell-mediated immune
response through recruitment of macrophages and T lymphocytes
which are HIV-susceptible cells and may facilitate HIV acquisition
[20,21]. In addition, oncogenic HPV and the presence of multiple
HPV genotypes are correlated with the presence of high-grade
lesions which could be the risky lesions for HIV acquisition [22].
What’s more, a direct interaction between HPV and HIV was also
suggested to contribute to this association [23,24]. Whatever,
vaccination based control of anal HPV infection will not only
prevent HPV related diseases but also regarded to be a promising
tool forpreventionofHIVinfection[11,13,17].In China, MSM is a
high-risk population for STDs including HIV infection [25]. It is
necessary to pay attention to this population with respect to anal
HPV infection and its related diseases.
High prevalence of HIV and anal HPV infection was observed in
ourstudysubjects,which isconsistent with thereportsfrom Western
countries. HPV06, HPV16, HPV52, and HPV11 were found to be
most frequently identified types among study population. But a
different type distribution was observed by HIV status, the
prevalence of several HPV types was significantly higher among
HIV positives than among negatives. A potential underlying
mechanism might be the association between HIV acquisition
and HPV infection was type dependent. Recently, Auvert and his
colleagues reported that high-risk HPV, but not low-risk HPV, was
significantly associated with HIV incidence [11]. However, the
effect of low-risk HPV was assessed after controlling for the status of
high-risk HPV. It is not clear whether the authors considered the
influenceof those who werehigh-riskand low-risk HPVco-infected.
In our study, the subjects were grouped into three subgroups
according to HPV type (as shown in Table 3): positive only for high-
riskHPV, positiveonlyforlow-risk HPV, and positivefor both.Our
results suggested both low-risk and high-risk HPV were associated
with increased HIV seropositivity, and the association for the latter
one was moderately higher. Besides varied strength of the
association for different HPV type, a possible effect of HIV
infection on the natural history of HPV could not be excluded. It is
suggested that cell-mediated immune response to HPV is lacking as
a result of HIV infection and contributes to reactivation of a latent
HPV infection [24]. Further studies are warranted to clarify the
underlying mechanisms for the different HPV type distribution
between HIV negatives and positives.
Actually, there is a debate on the direction of the causal link
between HIV acquisition and HPV infection. Several studies have
focused on the effects of HIV infection on HPV prevalence and
suggested that HIV infection induced immune depression
increased the risk of HPV infection [26–30]. Despite its biology
plausibility, our present study observed a significant relationship
between HIV seropositivity and multiplicity of HPV types, which
is consistent with the report by Chin-Hong and colleagues [12].
This finding provides a further evidence to support the causality
link suggested by prospective studies [12,13]. However, we can not
exclude a possibility that the relation is true in both directions due
to the limitation of our study design. The complicated interaction
between HPV and HIV and its impact on the development of
clinical outcomes should be further investigated. To evaluate the
protective effect of HPV vaccine against HIV acquisition would be
a reasonable and valuable way to explore the underlying key
mechanism [31].
In the interpretation of our data, some limitations have to be
considered. First, data of socio-demographic and risk behaviors
were based on an interview based standardized questionnaire.
Potential bias caused by inaccurate response can therefore not be
excluded. Second, our study participants might not represent the
general MSM population in the two sites due to the potential
limitation of enrollment methods. Potential selection bias should
Table 3. The association of anal HPV infection with HIV-1 seropositivity by oncogenic type and multiplicity of HPV types.
Anal infection of 26 HPV types
Prevalence of HIV-1 seropositivity
n/N (%) OR (95% CI) Adjusted OR* (95% CI)
By oncogenic type
Negative for any type 2/219 (0.9) Ref. Ref.
Only Positive for low-risk type 9/86 (10.5) 9.35 (2.47–35.41) 8.62 (2.22–33.44)
Only Positive for high-risk type 27/181 (14.9) 14.03 (4.18–47.03) 11.84 (3.47–40.48)
Positive for both 12/92 (13.0) 12.00 (3.30–43.60) 9.90 (2.67–36.73)
By multiplicity of HPV types
0 2/219 (0.9) Ref. Ref.
1 21/190 (11.1) 9.94 (2.92–33.86) 8.71 (2.51–30.27)
2 17/115 (14.8) 13.88 (3.98–48.42) 11.54 (3.25–40.98)
3 5/32 (15.6) 14.82 (3.35–65.45) 14.44 (3.15–66.13)
$4 5/22 (22.7) 23.53 (5.18–106.89) 16.12 (3.33–77.99)
p for trend ,0.001 ,0.001
Abbreviation: CI, confidence intervals; OR, odds ratio.
*Adjusted for age, ethnicity, education, age at the first homosexual act, frequency of homosexual behaviors in the past 6 months and ever found sexual partners in gay
venues.
doi:10.1371/journal.pone.0015256.t003
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should be kept in mind that HPV infected cells might not be
collected successfully using the current sampling method, and
accuracy of the test results might also be influenced by the quality
of the samples. Fourth, cross-sectional study design has its
limitation on association analysis. Nevertheless, our results
provided evidence to the findings of studies from countries other
than China [11–13].
In conclusion, high prevalence of HIV seropositivity and anal
HPV infection was observed among MSM from Beijing and
Tianjin, China. HPV infection was identified as an independent
predictor for HIV infection. Different distribution of HPV type by
HIV status suggested a HPV type dependent interaction. If the
causal link between HPV and HIV infection was confirmed by
further studies, it would be a potential strategy to reduce the
acquisition of HIV infection through application of HPV vaccine
in the MSM population.
Materials and Methods
Ethic statement
The study was approved by the Ethics Committees of the
Institute of Pathogen Biology, Chinese Academy of Medical
Sciences & Peking Union Medical College. Written informed
consent was obtained from each study participant before the
interview and testing.
Study population
Study participants were recruited from sites in 2 cities (Beijing
and Tianjin), between March and July 2010, though local non-
government organizations (Beijing Rainbow Volunteers Worksta-
tion and Tianjin Deep Blue Volunteers Workgroup). Multiple
methods were used for recruitment including website advertise-
ment, distributing flyers with study-related information at MSM-
frequented venues (e.g., MSM clubs, bars, parks and bathhouses),
and eligible study participants were also encouraged to refer their
peers to attend the study. Those eligible to participate were males,
at least 18 years old, ever had homosexual behaviors, willing to
take tests for HIV/anal HPV infection and syphilis, and physically
able and willing to provide written informed consent. Those study
participants who were tested positive for HIV or any susceptible
symptoms for STDs were informed by study personnel confiden-
tially and referred to treatment at the Institute of STD/AIDS
Prevention and Treatment, Xicheng District Center for Disease
Prevention and Control, Beijing and the STD/AIDS clinic at
affiliated hospital of Tianjin Medical University.
Data collection
Data were collected using a questionnaire administered by a
trained interviewer in a private room. Each study participant was
assigned a unique code that was used to link the questionnaire and
specimens. Data were collected, including self-reported socio-
demographic characteristics (e.g., age, income, ethnicity, educa-
tion, employment, and marriage status), sexual behaviors in the
past 6 months, knowledge on STDs, history of STDs, and lifestyle
factors.
Sample collection and laboratory tests
Blood samples were collected for test of HIV serology. The HIV
infection status was determined by an enzyme immunoassay
(Wantai Biological Medicine Company, Beijing, China). And
positive tests were confirmed by HIV-1/2 Western blot assay (HIV
Blot 2.2 WB; Genelabs Diagnostics, Singapore).
Trained personnel at each site collected anal samples by
rotating a saline water moistened nylon flocked swab in the anal
canal for about 2 minutes. The swab was then kept in 3 mL of
sample transport medium for Tellgenplex
TM HPV DNA Test
(Tellgen Life Science, Shanghai, China). Tellgenplex
TM HPV
DNA Test is based on suspension bead array method to identify
HPV types. Suspension bead array is a technical based on
PCR,beads coated hybridization, flow cytometry, lasers and digital
signal processing. Target HPV DNA-specific probes can be coated
on the surface of spectrally addressable polystyrene beads. As the
beads are internally labeled with a ratio of two spectrally distinct
fluorophores, the bead lots are assignable to class-specific HPV
subtypes. Mixtures of different bead suspensions can be used in the
same well of a 96-well plate format allowing for multiplex analysis.
Tellgenplex
TM HPV DNA Test provides identification of 19
recommended high-risk subtypes (16, 18, 26, 31, 33, 35, 39, 45,
51, 52, 53, 55, 56, 58, 59, 66, 68, 82, and 83) which are associated
with cervical caner. Beside that, the kit also provides detection of 7
low-risk subtypes (6, 11, 40, 42, 44, 61, and 73). In order to
minimize the possible nonspecific competition between partial
probes, the manufacture suggests to report following types
combined: 26/55, 40/42/44, and 61/73.
Statistical analysis
Questionnaires were double entered and compared with
EpiData software (EpiData 3.02 for Windows, The Epi Data
Association Odense, Denmark). After cleaning, the data were then
converted and analyzed using Statistical Analysis System (SAS 9.1
for Windows; SAS Institute Inc., NC, USA).
Study population was characterized by site with respect to age,
ethnicity, education, marriage status, self-reported sexual orienta-
tion, ever had sex with women, age at the first homosexual act, is
anal sex a regular sex behavior, ever had STDs other than HIV,
and current status of HIV. Differences between sites in these
variables were assessed with Pearson chi-square test.
The associations of potential risk factors with HIV/HPV
infection were estimated by means of odds ratios (OR) and 95%
confidence intervals (95% CI) using unconditional logistic
regression. Age and other covariates with a significant association
in univariate analyses were included in a further multiple logistic
regression analysis. Stepwise backward multiple logistic regression
analysis was then used to identify those predictors that were
independently associated with HIV/HPV infection. The signifi-
cance level for the predictors to stay in the model was 0.05. In
order to investigate the combined effect of HPV types, the risk of
HIV seropositivity was then assessed according to the number of
HPV types in each sample. Tests for trend by were performed by
treating categories of the number as continuous variable in the
logistic regression analysis.
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